Source:http://linkedlifedata.com/resource/pubmed/id/18715851
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-8-21
|
pubmed:abstractText |
This study investigated the use of corrected 17-alpha-hydroxyprogesterone (17-OHP) values to detect congenital adrenal hyperplasia (CAH) in newborn infants. 17-OHP concentrations in blood spots from 913 neonates were measured using a neonatal screening test. A prematurity index was calculated using a scoring system based on gestational age and birth weight. Blood spot 17-OHP concentrations divided by the sum of prematurity scores were defined as the corrected 17-OHP values. Preterm infants (<30 wk) and low birth weight infants (<1.0 kg) showed 3.9- and 3.8-fold higher blood spot 17-OHP concentrations than normal full term infants. However, no significant differences were observed in the corrected 17-OHP values between the groups. Blood spot 17-OHP levels yielded significant correlations with the prematurity index (r = 0.42, p <0.05). Positive results for CAH were obtained in 9.5% (n = 53) and 2.0% (n = 11) of 556 premature infants by the cutoffs of blood spot 17-OHP (>15.0 ng/ml) and corrected 17-OHP values (>13.0 ng/ml), respectively. Of the 53 positive subjects, 39 (73.6%) converted to negative after 1 to 5 mo without treatment. In summary, blood spot 17-OHP levels are influenced by the prematurity of newborns. Use of corrected 17-OHP values provide limited but helpful information in screening for CAH by reducing the rate of false-positive results, especially in premature infants.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1550-8080
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
235-40
|
pubmed:meshHeading |
pubmed-meshheading:18715851-17-alpha-Hydroxyprogesterone,
pubmed-meshheading:18715851-Adrenal Hyperplasia, Congenital,
pubmed-meshheading:18715851-Adrenocorticotropic Hormone,
pubmed-meshheading:18715851-Birth Weight,
pubmed-meshheading:18715851-Gestational Age,
pubmed-meshheading:18715851-Humans,
pubmed-meshheading:18715851-Infant, Newborn,
pubmed-meshheading:18715851-Infant, Premature,
pubmed-meshheading:18715851-Infant, Premature, Diseases,
pubmed-meshheading:18715851-Reference Values,
pubmed-meshheading:18715851-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
|
pubmed:affiliation |
Departments of Pediatrics, College of Medicine, Inha University, Incheon, South Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|